| |
Latest 10 SEC filings (by transaction date) for GLSI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,000 | $19.08 |
Mar 26/24 | Mar 22/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 2,500 | $19.98 |
Mar 22/24 | Mar 20/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $17.68 |
Mar 7/24 | Mar 5/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,500 | $12.49 |
Mar 7/24 | Mar 5/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 30,500 | $12.49 |
Mar 6/24 | Mar 4/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 4,100 | $13.03 |
Feb 21/24 | Feb 16/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 10,800 | $11.16 |
Feb 20/24 | Feb 15/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 12,700 | $11.07 |
Nov 14/23 | Nov 10/23 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 5,000 | $10.17 |
Nov 7/23 | Nov 3/23 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,500 | $9.11 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for GLSI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 3/24 | Apr 1/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,000 | $19.08 |
Mar 26/24 | Mar 22/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 2,500 | $19.98 |
Mar 22/24 | Mar 20/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 1,500 | $17.68 |
Mar 7/24 | Mar 5/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,500 | $12.49 |
Mar 7/24 | Mar 5/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 30,500 | $12.49 |
Mar 6/24 | Mar 4/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 4,100 | $13.03 |
Feb 21/24 | Feb 16/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 10,800 | $11.16 |
Feb 20/24 | Feb 15/24 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 12,700 | $11.07 |
Nov 14/23 | Nov 10/23 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 5,000 | $10.17 |
Nov 7/23 | Nov 3/23 | Patel Snehal | Direct Ownership | Common Stock | P - Open market or private purchase | 3,500 | $9.11 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Intra-Cellular Therapies (OQ:ITCI) |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |